In their proposed risk stratification system, patients are considered high-risk BCR if they had an ISUP grade group 4 or 5 prior to RT, or they had an interval from nadir to BCR of ≤18 months, whereas patients with a lower-grade PCa prior to treatment and longer interval to BCR are considered low risk [25]. The gene discussed is BCR; the disease is posterior cortical atrophy.